Rizvi NA - Search Results

1

A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma.

Popa IE, Stewart K, Smith FP, Rizvi NA. Popa IE, et al. Among authors: rizvi na. Cancer. 2002 Oct 15;95(8):1714-9. doi: 10.1002/cncr.10843. Cancer. 2002. PMID: 12365019 Free article. Clinical Trial.

2

Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

Rizvi NA, Marshall JL, Ness E, Yoe J, Gill GM, Truglia JA, Loewen GR, Jaunakais D, Ulm EH, Hawkins MJ. Rizvi NA, et al. Clin Cancer Res. 1998 Jun;4(6):1437-42. Clin Cancer Res. 1998. PMID: 9626460 Clinical Trial.

3

A Phase I study of LGD1069 in adults with advanced cancer.

Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, Gill GM, Ulm EH, Geiser R, Jaunakais D, Hawkins MJ. Rizvi NA, et al. Clin Cancer Res. 1999 Jul;5(7):1658-64. Clin Cancer Res. 1999. PMID: 10430065 Clinical Trial.

4

Docetaxel (Taxotere) and gemcitabine in combination therapy.

Rizvi NA. Rizvi NA. Semin Oncol. 1999 Jun;26(3 Suppl 11):19-22. Semin Oncol. 1999. PMID: 10458206 Review.

5

A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A, Hawkins MJ. Bhargava P, et al. Clin Cancer Res. 1999 Aug;5(8):1989-95. Clin Cancer Res. 1999. PMID: 10473076 Clinical Trial.

6

Docetaxel and gemcitabine combinations in non-small cell lung cancer.

Rizvi NA, Spiridonidis CH, Davis TH, Bhargava P, Marshall JL, Dahut W, Figuera M, Hawkins MJ. Rizvi NA, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):27-31; discussion 41-2. Semin Oncol. 1999. PMID: 10585006 Review.

7

A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.

Chen HX, Marshall JL, Ness E, Martin RR, Dvorchik B, Rizvi N, Marquis J, McKinlay M, Dahut W, Hawkins MJ. Chen HX, et al. Clin Cancer Res. 2000 Apr;6(4):1259-66. Clin Cancer Res. 2000. PMID: 10778949 Clinical Trial.

8

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Fried K, Williams M, Lefebvre P, Dahut W, Hanfelt J, Gehan E, Figuera M, Hawkins MJ, Rizvi NA. Bhargava P, et al. Among authors: rizvi na. Cancer Chemother Pharmacol. 2001 Aug;48(2):95-103. doi: 10.1007/s002800100317. Cancer Chemother Pharmacol. 2001. PMID: 11561784 Clinical Trial.

9

A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

Bhargava P, Marshall JL, Dahut W, Rizvi N, Trocky N, Williams JI, Hait H, Song S, Holroyd KJ, Hawkins MJ. Bhargava P, et al. Clin Cancer Res. 2001 Dec;7(12):3912-9. Clin Cancer Res. 2001. PMID: 11751482 Clinical Trial.

10

Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.

Rizvi NA, Marshall JL, Ness E, Hawkins MJ, Kessler C, Jacobs H, Brenckman WD Jr, Lee JS, Petros W, Hong WK, Kurie JM. Rizvi NA, et al. J Clin Oncol. 2002 Aug 15;20(16):3522-32. doi: 10.1200/JCO.2002.02.090. J Clin Oncol. 2002. PMID: 12177113 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters